WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2001089527) PHARMACEUTICAL COMPOSITION COMPRISING LORATADINE AND A NASAL DECONGESTANT
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2001/089527    International Application No.:    PCT/US2001/016570
Publication Date: 29.11.2001 International Filing Date: 22.05.2001
Chapter 2 Demand Filed:    25.05.2000    
IPC:
A61K 31/137 (2006.01), A61K 31/445 (2006.01)
Applicants: SCHERING CORPORATION [US/US]; 2000 Galloping Hill Road Kenilworth, NJ 07033-0530 (US) (For All Designated States Except US).
ULLOA LUGO, Sergio, Rolando [MX/MX]; (MX) (For US Only).
VILLACAMPA RAMOS, Jose, De Jesus [MX/MX]; (MX) (For US Only)
Inventors: ULLOA LUGO, Sergio, Rolando; (MX).
VILLACAMPA RAMOS, Jose, De Jesus; (MX)
Agent: HOFFMAN, Thomas, D.; Schering Corporation Patent Department - K-6-1 1990 2000 Galloping Hill Road Kenilworth, NJ 07033-0530 (US)
Priority Data:
005129 24.05.2000 MX
Title (EN) PHARMACEUTICAL COMPOSITION COMPRISING LORATADINE AND A NASAL DECONGESTANT
(FR) COMPOSITIONS SOLIDES ET LIQUIDES STABLES
Abstract: front page image
(EN)Stable pharmaceutical compositions containing non-sedating antihistamines such as loratadine and a nasal decongestant such as pseudoephedrine sulfate and at least one pharmaceutically acceptable carrier, and stable pharmaceutical compositions containing non-sedating antihistamines such as loratadine, nasal decongestants such as pseudoephedrine, and an expectorant such as Ambroxol and at least one pharmaceutically acceptable carrier which are stable to chemical and physical degradation and microbial contamination are disclosed.
(FR)L'invention concerne des compositions pharmaceutiques stables contenant des antihistaminiques non sédatifs tels que la loratadine et un décongestionnant nasal tel que du sulfate de pseudoéphédrine, et au moins un entraîneur pharmaceutiquement acceptable, ainsi que des compositions pharmaceutiques stables contenant des antihistaminiques non sédatifs tels que la loratadine, des décongestionnants nasaux tels que de la pseudoéphédrine, et un expectorant tel que l'Ambroxol et au moins un entraîneur pharmaceutiquement acceptable, lesquelles compositions sont stables face à la dégradation chimique et physique et à la contamination microbienne.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, HR, HU, ID, IL, IN, IS, JP, KG, KR, KZ, LC, LK, LR, LT, LU, LV, MA, MD, MG, MK, MN, MX, MZ, NO, NZ, PL, PT, RO, RU, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)